Pulmotan

Composition
Each film-coated tablet contains:
Bosentan Monohydrate eq. to Bosentan…125 mg
Excipients………q.s.

THERAPEUTIC INDICATIONS
Primary arterial pulmonary hypertension (idiopathic and hereditary).
Secondary arterial pulmonary hypertension to scleroderma without significant interstitial pulmonary disease.
Arterial pulmonary hypertension associated with inborn systemic-pulmonary short circuits and Eisenmenger syndrome.

DOSAGE

Adults: starts with 62.5 mg/12 hr during 4 weeks, increase to 125 mg/12 hr

PRESENTATIONS
Carton containing 60 film-coated tablets in blister pack.